2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with Colonic Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Awrey, DE; Ban, F; Beletskaya, I; Bray, MR; Che, Y; Chirgadze, NY; Edwards, L; Feher, M; Fletcher, GC; Forrest, B; Hodgson, R; Kiarash, R; Lang, Y; Laufer, R; Li, SW; Lin, DC; Liu, Y; Madeira, B; Mak, TW; Mao, G; Mason, JM; Ng, G; Patel, NK; Pauls, HW; Plotnikova, O; Qiu, W; Sampson, PB; Wei, X | 1 |
Abassi, Y; Daams, R; Fezai, M; JemaĆ , M; Kifagi, C; Lang, F; Massoumi, R | 1 |
Drag, M; Groborz, K; Poreba, M; Rut, W; Salvesen, GS; Snipas, SJ | 1 |
3 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Colonic Neoplasms
Article | Year |
---|---|
The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents.
Topics: Administration, Oral; Animals; Cell Cycle Proteins; Cell Line, Tumor; Colon; Colonic Neoplasms; Crystallography, X-Ray; Female; Humans; Indazoles; Mice, Nude; Models, Molecular; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2015 |
Reversine inhibits Colon Carcinoma Cell Migration by Targeting JNK1.
Topics: Animals; Anthracenes; Cell Line; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Humans; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Mitogen-Activated Protein Kinase 8; Molecular Targeted Therapy; Morpholines; Purines; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells.
Topics: Apoptosis; Caspase 2; Colonic Neoplasms; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; HCT116 Cells; Humans; Morpholines; Proto-Oncogene Proteins c-mdm2; Purines; Substrate Specificity | 2019 |